Speakers

Dr Suzanne Dilly is an experienced entrepreneurial scientist. After commercialising her Chemical Biology post-doctoral research in the University of Warwick spin-out, a2sp Limited, Suzanne was awarded a prestigious Royal Society of Edinburgh Enterprise Fellowship, during which formal commercial and entrepreneurial training completed her transition from lab to boardroom.

Presentation Title: Navigating a Pathway to New CRO Launch

Abstract: ValiRx launched Inaphaea BioLabs earlier this year to service internal preclinical pipeline discovery needs, but also to offer a service of cell-based assays to the wider industry.  Dr Suzy Dilly will reflect on the process of setting up a brand new lab; launching the new services – the twist of the acquisition of a massive biobank of patient derived cells from Imagen Therapeutics; and our vision for Inaphaea for the future.

View company profile